DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

DAICHI vs SUDARSHAN: Stock Comparison

DAICHI vs SUDARSHAN PHARMA INDUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

DAICHI shows a lower P/E and a higher dividend yield, while SUDARSHAN PHARMA IND shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DAICHI leads 4; SUDARSHAN leads 3 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DAICHISUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹219 Cr
₹0 Cr
P/E RatioDAICHI has the lower reading
0x ✓
28.27x
P/B RatioDAICHI has the lower reading
1.32x ✓
4.11x
EPSDAICHI has the higher reading
₹1.21 ✓
₹0.32
Book ValueContext only
₹247.78
₹6.14
Dividend YieldDAICHI has the higher reading
0.51% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
DAICHI has a lower P/E
0x vs 28.27x
P/B Ratio
DAICHI has a lower P/B
1.32x vs 4.11x
EPS
DAICHI has higher earnings per share
₹1.21 vs ₹0.32
Dividend Yield
DAICHI has a higher dividend yield
0.51% vs 0%
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs -6.45%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs -69.28%
Net Margin
SUDARSHAN has a higher net margin
0% vs -0.46%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricDAICHISUDARSHAN
Live Price₹364.8₹32.71
Day Change-1.34%0.03%
Volume5,04392,985
52-Week High₹374.7₹39.3
52-Week Low₹229.9₹31.01
Distance from 52W High-2.64%-16.77%

Valuation

MetricDAICHISUDARSHAN
Market Cap₹219 Cr₹0 Cr
P/E Ratio0x28.27x
P/B Ratio1.32x4.11x
EPS₹1.21₹0.32
Book Value₹247.78₹6.14
Dividend Yield0.51%0%

Growth

MetricDAICHISUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-6.45%24.4%
Qtr Profit Growth-69.28%38.7%

Profitability & Leverage

MetricDAICHISUDARSHAN
ROE-0.33%—
ROCE0.28%—
Net Margin-0.46%0%
Operating Margin0.3%—
Debt to Equity0.08x—

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDAICHISUDARSHAN
Promoter Holding63.98%57.81%▼ 1.12 pp
FII Holding0%21.95%▲ 2.57 pp
DII Holding0%0%
Public Holding36.02%20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DAICHI and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.